XML 38 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Long-Term Debt and Notes Payable - Additional Information (Detail)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 02, 2017
USD ($)
Subsidiary
$ / shares
shares
May 31, 2016
USD ($)
BoardofDirector
Mar. 31, 2018
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2017
USD ($)
Apr. 26, 2018
USD ($)
Dec. 29, 2017
Line of Credit Facility [Line Items]              
Long-term debt     $ 60,868   $ 60,698    
Interest expense     2,035 $ 2,233      
Unsecured Promissory Notes              
Line of Credit Facility [Line Items]              
Debt instrument, maturity date   Apr. 01, 2019          
Debt instrument, interest rate   7.00%          
Proceeds from issuance of notes   $ 25,000          
Debt instrument, payable number | BoardofDirector   2          
PIK interest payments         2,040    
Subsequent Event | Unsecured Promissory Notes              
Line of Credit Facility [Line Items]              
Notes outstanding principal balance           $ 27,040  
New Credit Agreement              
Line of Credit Facility [Line Items]              
Long-term debt     $ 65,000        
New Credit Agreement | Unsecured Promissory Notes              
Line of Credit Facility [Line Items]              
Debt instrument, payment-in-kind interest rate 8.00%            
Debt instrument, payment terms     Interest payments at 8.00% until the lenders under the New Credit Agreement receive two consecutive semi-annual cash interest payments.        
Debt instrument, frequency of periodic payment     Semi-annual        
Wilks | New Credit Agreement              
Line of Credit Facility [Line Items]              
Long-term debt $ 65,000            
Debt instrument, maturity date     Dec. 31, 2022        
Debt instrument, interest rate 9.00%            
Number of operating subsidiaries | Subsidiary 2            
Period for payment of Interest on loan in kind 2 years            
Debt instrument, payment-in-kind interest rate 11.00%            
Notice of intent, period required to provide to exercise available option for interest payment 30 days            
Unamortized debt issuance costs     $ 811        
Warrants exercise price per share | $ / shares $ 14.91            
Warrants expiration date Dec. 31, 2022            
Percentage of common stock outstanding owned             11.30%
Percentage of common stock outstanding would hold upon exercise of warrant to purchase additional shares 12.90%            
Wilks | New Credit Agreement | Maximum              
Line of Credit Facility [Line Items]              
Warrant entitles to purchase shares of the common stock | shares 523,022            
Wilks | New Credit Agreement | Warrant              
Line of Credit Facility [Line Items]              
Unamortized original issue discount     3,321        
Wells Fargo | Amended Credit Agreement | Standby Letters of Credit              
Line of Credit Facility [Line Items]              
Line of credit, maximum borrowing capacity     $ 7,775   $ 9,230